Cymabay Therapeutics Inc Watch

from 10-K 69 pages Certain Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Both (I) Not Material and (II) Is the Type of Information That Cymabay Treats as Private or Confidential. Sublease

from 10-K 4 pages Second Amendment to Lease

from 10-K 6 pages Cymabay Therapeutics, Inc. Rsu Award Grant Notice

from 8-K 1 page Cymabay Therapeutics, Inc. Non-Employee Directors Compensation Program

from 10-Q 23 pages Cymabay Therapeutics, Inc. 2020 New Hire Plan Adopted by the Board of Directors: October 21, 2020 Amended and Restated by the Board of Directors: July 11, 2023

from 8-K 17 pages 2. Background Check/References. Employment at the Company Is Conditioned Upon Passing a Background Check. Waivers Necessary to Authorize This Process Will Be Sent to You by Email From Advanced Reporting. Please Sign and Return the Waiver Forms Electronically According to the Instructions You Will Receive From Them. This Employment Offer Is Also Contingent Upon Completion of Satisfactory Reference Checks. 3. Compensation and Employee Benefits

from 10-K 63 pages Collaboration and License Agreement

from 8-K 8 pages February 17, 2023 Dennis Kim Chief Medical Officer Re: Notice of Resignation and Transition Agreement

from 10-Q 33 pages Ppar-D License Agreement

from 10-Q 71 pages Development Financing Agreement by and Between Cymabay Therapeutics, Inc. and Abw Cyclops Spv LP Dated July 30, 2021 Development Financing Agreement

from 10-Q 18 pages Material contract

from 10-Q 18 pages 2. Background Check. Employment at the Company Is Conditioned Upon Passing a Background Check. Waivers Necessary to Authorize This Process Will Be Sent to You by Email From Advanced Reporting. Please Sign and Return the Waiver Forms Electronically According to the Instructions You Will Receive From Them. 3. Compensation and Employee Benefits

from 10-K 18 pages 1. Position, Duties and Responsibilities. Subject to the Terms Set Forth Herein, the Company Agrees to Employ You in the Position of General Counsel. You Will Report to the Company’s Chief Executive Officer (“CEO”) and Will Perform Such Duties as Are Assigned to You by the CEO. You Will Devote Your Full Business Time and Attention to the Business Affairs of the Company, Except for Reasonable Vacations and Periods of Illness or Incapacity Permitted by the Company’s General Employment Policies. the Employment Relationship Between You and the Company Shall Also Be Governed by the General Employment Policies and Practices of the Company, Including Those Relating to Protection of Confidential Information and Assignment of Inventions, Except That When the Terms of This Letter Agreement Differ From, or Are in Conflict With, the Company’s General Employment Policies or Practices, This Letter Agreement Shall Control. Subject to the Other Terms of This Letter Agreement, the Company May Change Your Position, Duties, Reporting Relationship and Work Location From Time to Time in Its Discretion. 2. Compensation and Employee Benefits

from 10-K 11 pages Cymabay Therapeutics, Inc. Stock Option Grant Notice

from 10-K 23 pages Cymabay Therapeutics, Inc. 2020 New Hire Plan Adopted by the Board of Directors: October 21, 2020

from 10-Q 18 pages 2.background Check. Employment at the Company Is Conditioned Upon Passing a Background Check. Waivers Necessary to Authorize This Process Will Be Sent to You by Email From Advanced Reporting. Please Sign and Return the Waiver Forms Electronically According to the Instructions You Will Receive From Them. 3. Compensation and Employee Benefits

from 10-K 1 page Cymabay Therapeutics, Inc. Non-Employee Directors Compensation Program

from 10-K 12 pages 1.position, Duties and Responsibilities. Subject to the Terms Set Forth Herein, the Company Agrees to Employ You in the Position of Senior Vice President, Regulatory Affairs and Quality Assurance and You Hereby Accept Such Employment Effective Immediately. You Will Report to the Company’s Chief Executive Officer (The “CEO”) and Will Perform Such Duties as Are Assigned to You by the CEO. You Will Devote Your Full Business Time and Attention to the Business Affairs of the Company, Except for Reasonable Vacations and Periods of Illness or Incapacity Permitted by the Company’s General Employment Policies. the Employment Relationship Between You and the Company Shall Also Be Governed by the General Employment Policies and Practices of the Company, Including Those Relating to Protection of Confidential Information and Assignment of Inventions, Except That When the Terms of This Letter Agreement Differ From, or Are in Conflict With, the Company’s General Employment Policies or Practices, This Letter Agreement Shall Control. Subject to the Other Terms of This Letter Agreement, the Company May Change Your Position, Duties, Reporting Relationship and Work Location From Time to Time in Its Discretion. 2. Compensation and Employee Benefits

from 10-Q 13 pages 1.position, Duties and Responsibilities. Subject to the Terms Set Forth Herein, the Company Agrees to Employ You in the Position of General Counsel and Secretary and You Hereby Accept Such Employment Effective Immediately. You Will Report to the Company’s Chief Executive Officer (The “CEO”) and Will Perform Such Duties as Are Assigned to You by the CEO. You Will Devote Your Full Business Time and Attention to the Business Affairs of the Company, Except for Reasonable Vacations and Periods of Illness or Incapacity Permitted by the Company’s General Employment Policies. the Employment Relationship Between You and the Company Shall Also Be Governed by the General Employment Policies and Practices of the Company, Including Those Relating to Protection of Confidential Information and Assignment of Inventions, Except That When the Terms of This Letter Agreement Differ From, or Are in Conflict With, the Company’s General Employment Policies or Practices, This Letter Agreement Shall Control. Subject to the Other Terms of This Letter Agreement, the Company May Change Your Position, Duties, Reporting Relationship and Work Location From Time to Time in Its Discretion. 2. Compensation and Employee Benefits

from 8-K 26 pages Cymabay Therapeutics, Inc. 2013 Equity Incentive Plan Adopted by the Board of Directors: September 25, 2013 Approved by the Stockholders: September 30, 2013 Effective Date: September 25, 2013 Amended by the Board of Directors: March 18, 2014 Approved by the Stockholders: June 3, 2014 Amended by the Board of Directors: March 30, 2018 Approved by the Stockholders: June 5, 2018